Book a demo
Skip to content

Stonewake Monitoring

Plus Therapeutics files 8-K reporting a debt obligation

Plus Therapeutics, Inc. filed an 8-K on September 10, 2026 covering a debt obligation, following a going concern disclosure in its recent quarterly filing.

Export financeUSAPublished · 3 sourced facts

Plus Therapeutics, Inc., a Delaware-incorporated surgical and medical instruments company trading on Nasdaq under the ticker PSTV, filed an 8-K dated September 10, 2026.[1][2]

The filing, with accession number 0001193125-26-387267 and a period ending September 4, 2026, reports a debt obligation and covers items 1.01, 2.03, 3.02, 8.01, and 9.01.[1]

The company's prior 10-Q, filed August 14, 2026, contained a going concern disclosure.[3]

Sources

  1. [1]SEC EDGAR: 8-K, 0001193125-26-387267, 10 Sep 2026
  2. [2]SEC EDGAR: CIK 0001095981, PLUS THERAPEUTICS, INC.
  3. [3]SEC EDGAR: 10-Q, 0001193125-26-352444, 14 Aug 2026

SEC EDGAR

← All briefs